Talphera TLPH
NASDAQ TLPH
$1.08 +0.01 (+0.93%)
As of: Oct 21, 2026 · 12:44 PM EDT

Talphera (TLPH) Restructuring Costs (2015)

Updated

Talphera (TLPH) recorded Restructuring Costs of $756,000 in FY2015.

Analysis

Talphera (TLPH) Restructuring Costs (2015) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,134.13 Bn 1,102.72 Bn 19.71 Bn
2 Johnson & Johnson 616.20 Bn 534.73 Bn 17.26 Bn
3 AbbVie 501.09 Bn 474.20 Bn 12.70 Bn
4 Merck 367.41 Bn 321.79 Bn 12.21 Bn
5 Novartis Ag 297.88 Bn 261.87 Bn 11.24 Bn
6 Astrazeneca 261.36 Bn 235.05 Bn 12.86 Bn
7 Amgen 235.80 Bn 191.20 Bn 7.24 Bn
8 Gilead Sciences 190.78 Bn 164.97 Bn 6.22 Bn
9 Pfizer 169.43 Bn 116.08 Bn 10.94 Bn
10 Talphera 81.57 Mn 64.49 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2015 2,000.00
Mar 31, 2015 754,000.00
API Access

Talphera Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=TLPH&period=max&api_key=YOUR_API_KEY